MLCO Stock Analysis: Melco Resorts | NASDAQ
Resorts & Casinos | NASDAQ, USA | Market Cap: 1.734m USD | 12M Return: -53.9% | US5854641009 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 9.00M
Qual. Beats: 0
Rev. Trend: 89.8%
Qual. Beats: -1
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Melco Resorts & Entertainment Limited (NASDAQ: MLCO) is a Hong Kong-based integrated resort operator that develops, owns, and operates casino gaming and entertainment facilities across multiple jurisdictions, including Macau, the Philippines, Cyprus, and Sri Lanka. The company was founded in 2003 and operates as a subsidiary of Melco Leisure and Entertainment Group Limited. Its portfolio features flagship properties such as City of Dreams, Studio City, and Altira Macau in Cotai and Taipa, along with City of Dreams Manila in the Philippines and City of Dreams Mediterranean in Cyprus.
Melcos business model centers on the integrated resort concept, combining casino gaming (tables and machines) with hotels, dining, retail, and entertainment venues such as performance theaters, spas, and convention facilities. The company also operates Mocha Clubs, a chain of electronic gaming machine venues in Macau, and three satellite casinos in Cyprus. Following its 2017 rebranding from Melco Crown Entertainment, the company has continued to expand internationally with development projects in additional markets, reflecting the broader industry trend among major gaming operators seeking diversification beyond their traditional home markets.
- Macau gaming revenue recovery hinges on Chinese tourist arrivals
- Concession license renewal risk looms as 2025 deadline approaches
- City of Dreams Mediterranean ramp-up diversifies revenue beyond Macau
| Net Income: 235.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 2.29 > 1.0 |
| NWC/Revenue: 0.30% < 20% (prev 3.87%; Δ -3.57% < -1%) |
| CFO/TA 0.11 > 3% & CFO 818.1m > Net Income 235.1m |
| Net Debt (6.42b) to EBITDA (1.19b): 5.41 < 3 |
| Current Ratio: 1.01 > 1.5 & < 3 |
| Outstanding Shares: last quarter (388.7m) vs 12m ago -6.94% < -2% |
| Gross Margin: 31.79% > 18% (prev 35.75%; Δ -3.96% > 0.5%) |
| Asset Turnover: 68.86% > 50% (prev 63.06%; Δ 5.80% > 0%) |
| Interest Coverage Ratio: 1.41 > 6 (EBIT TTM 644.8m / Interest Expense TTM 456.4m) |
| A: 0.00 (Total Current Assets 1.15b - Total Current Liabilities 1.14b) / Total Assets 7.37b |
| B: -0.51 (Retained Earnings -3.73b / Total Assets 7.37b) |
| C: 0.08 (EBIT TTM 644.8m / Avg Total Assets 7.59b) |
| D: -0.19 (Book Value of Equity -1.64b / Total Liabilities 8.70b) |
| Altman-Z'' = -1.26 = CCC |
| DSRI: 0.86 (Receivables 119.7m/131.4m, Revenue 5.23b/4.93b) |
| GMI: 1.12 (GM 35.75% / 31.79%) |
| AQI: 0.56 (AQ_t 0.08 / AQ_t-1 0.14) |
| SGI: 1.06 (Revenue 5.23b / 4.93b) |
| TATA: -0.08 (NI 235.1m - CFO 818.1m) / TA 7.37b) |
| Beneish M = -3.25 (Cap -4..+1) = AA |
As of November 13, 2026, the stock is trading at USD 4.18 with a total of 2,100,056 shares traded. Over the past week, the price has changed by -8.33%, over one month by -0.95%, over three months by -24.28% and over the past year by -53.91%.
Current recommended Stop Loss: 3.90 (which is 6.7% or 1.6 ATR below the current price).
Melco Resorts has received a consensus analysts rating of 4.08. Therefore, it is recommended to buy MLCO.
- StrongBuy: 6
- Buy: 2
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 6.2 | 47.8% |
P/E Trailing = 11.122
P/E Forward = 9.9108
P/S = 0.3321
P/B = 204.1201
P/EG = 0.5849
Revenue TTM = 5.23b USD
EBIT TTM = 644.8m USD
EBITDA TTM = 1.19b USD
Long Term Debt = 5.07b USD (from longTermDebt, last quarter)
Short Term Debt = 65.7m USD (from shortTermDebt, last quarter)
Debt = 7.33b USD (from shortLongTermDebtTotal, last quarter) + Leases 20.7m
Net Debt = 6.42b USD (calculated: Debt 7.33b - CCE 912.9m)
Enterprise Value = 8.15b USD (1.73b + Debt 7.33b - CCE 912.9m)
Interest Coverage Ratio = 1.41 (Ebit TTM 644.8m / Interest Expense TTM 456.4m)
EV/FCF = 17.12x (Enterprise Value 8.15b / FCF TTM 476.1m)
FCF Yield = 5.84% (FCF TTM 476.1m / Enterprise Value 8.15b)
FCF Margin = 9.11% (FCF TTM 476.1m / Revenue TTM 5.23b)
Net Margin = 4.50% (Net Income TTM 235.1m / Revenue TTM 5.23b)
Gross Margin = 31.79% ((Revenue TTM 5.23b - Cost of Revenue TTM 3.57b) / Revenue TTM)
Gross Margin QoQ = 24.39% (prev 27.23%)
Tobins Q-Ratio = 1.11 (Enterprise Value 8.15b / Total Assets 7.37b)
Interest Expense / Debt = 6.23% (Interest Expense 456.4m / Debt 7.33b)
Taxrate = 0.61% (1.17m / 191.2m)
NOPAT = 640.8m (EBIT 644.8m * (1 - 0.61%))
Current Ratio = 1.01 (Total Current Assets 1.15b / Total Current Liabilities 1.14b)
Debt / Equity = -4.48 (negative equity) (Debt 7.33b / totalStockholderEquity, last quarter -1.64b)
Debt / EBITDA = 5.41 (Net Debt 6.42b / EBITDA 1.19b)
Debt / FCF = 13.48 (Net Debt 6.42b / FCF TTM 476.1m)
Total Stockholder Equity = -1.35b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.10% (Net Income 235.1m / Total Assets 7.37b)
RoE = -17.37% (negative equity) (Net Income TTM 235.1m / Total Stockholder Equity -1.35b)
RoCE = 17.33% (EBIT 644.8m / Capital Employed (Equity -1.35b + L.T.Debt 5.07b))
RoIC = 10.61% (NOPAT 640.8m / Invested Capital 6.04b)
WACC = 6.80% (E(1.73b)/V(9.06b) * Re(9.41%) + D(7.33b)/V(9.06b) * Rd(6.23%) * (1-Tc(0.01)))
Discount Rate = 9.41% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -96.96 | Cagr: -5.33%
[DCF] Terminal Value 77.97% ; FCFF base≈415.9m ; Y1≈476.7m ; Y5≈701.6m
[DCF] Fair Price = 10.89 (EV 10.6b - Net Debt 6.42b = Equity 4.14b / Shares 380.2m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.67 | # QB: 0
Revenue Correlation: 89.82 | Revenue CAGR: 17.58% | SUE: -1.34 | # QB: -1
EPS current Quarter (2027-03-31): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=0.40 | Chg30d=-6.35% | Revisions=-25% | GrowthEPS=-42.8% | GrowthRev=-0.0%
EPS next Year (2027-12-31): EPS=0.61 | Chg30d=-15.66% | Revisions=-25% | GrowthEPS=+50.6% | GrowthRev=+3.4%
[Analyst] Revisions Ratio: -40% (up=0, down=2)